<SEC-DOCUMENT>0001485003-17-000091-index.html : 20171013 <SEC-HEADER>0001485003-17-000091.hdr.sgml : 20171013 <ACCEPTANCE-DATETIME>20171013160341 ACCESSION NUMBER: 0001485003-17-000091 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20171006 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20171013 DATE AS OF CHANGE: 20171013 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Eleven Biotherapeutics, Inc. CENTRAL INDEX KEY: 0001485003 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 262025616 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36296 FILM NUMBER: 171136670 BUSINESS ADDRESS: STREET 1: 245 FIRST STREET STREET 2: SUITE 1800 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-444-8550 MAIL ADDRESS: STREET 1: 245 FIRST STREET STREET 2: SUITE 1800 CITY: CAMBRIDGE STATE: MA ZIP: 02142 </SEC-HEADER> <DOCUMENT> <TYPE>8-K <SEQUENCE>1 <FILENAME>ebio-form8xkmccaberesignat.htm <DESCRIPTION>8-K <TEXT> Document 1 - file: ebio-form8xkmccaberesignat.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-10.1 <SEQUENCE>2 <FILENAME>consultingagremeent-fitzge.htm <DESCRIPTION>EXHIBIT 10.1 <TEXT> Document 2 - file: consultingagremeent-fitzge.htm
</DOCUMENT> </SEC-DOCUMENT>